Over twenty years ago, Dr. John Urquhart published a paper titled, “Patient Non-Compliance with Drug Regimens: Measurement, Clinical Correlates, Economic Impact.”[1] Urquhart argued that when patients skip doses, take medications off schedule or don’t adhere to trial requirements, Sponsors can arrive at erroneous conclusions. Since his publication, new trial designs and methods of statistical analysis […]
Continue Reading
